Given the clinicopathological significance of SLC1A5201 and the observation that the level of the SLC1A5 variant is negatively correlated with prognosis in several cancer types16, targeting the SLC1A5 variant is a promising strategy to starve cancer cells and induce antitumor effects. The gene discussed is SLC1A5; the disease is cancer.